Study on separation and purification process of C1 esterase inhibitor

Journal Title: Chinese Journal of Blood Transfusion - Year 2022, Vol 35, Issue 11

Abstract

Objective To study the technology of separating and purifying C1 esterase inhibitor (C1-INH) by using the waste washing liquid as raw materia during the preparation of human prothrombin complex (PCC) l. Methods C1-INH was isolated and purified by a two-step method of polyethylene glycol (PEG) 4000 precipitation and cation chromatography. The pH of raw materials and the concentration of PEG4000 were adjusted to investigate the optimal conditions of PEG4000 precipitation method. After PEG was precipitated and centrifuged, the supernatant is treated as the loading solution for cation exchange chromatography, using Fractogel EMD SE HiCap(M) gel and CM Sepharose FF gel for ion exchange chromatography. The most suitable gel and separation conditions were selected by comparing the C1-INH antigen yield, activity yield and specific activity. Results Under the condition of pH 6.1, when the mass fraction of PEG4000 was 14%, the recovery rate of C1 esterase inhibitor was close to 70%, and the removal rate of ceruloplasmin was more than 95% after stirring for 10 minutes. As fractogel EMD SE HiCap(M) gel was used for cation exchange chromatography, when the eluent salt concentration was 0.25 M sodium chloride, the activity yield of C1 esterase inhibitor was greater than 80%, and the specific activity was greater than 5 IU/mg. Conclusions Using the waste washing liquid as the raw material during the preparation of PCC, the C1 esterase inhibitor with high specific activity can be prepared through PEG precipitation and purification by Fractogel EMD SE HiCap(M) ion exchange chromatography.

Authors and Affiliations

Jiabin XU, Yawen LI, Jiali GONG, Erhua LUO, Meng ZHANG

Keywords

Related Articles

Performance evaluation of nucleic acid testing system for blood screening in high-altitude areas

Objective To validate the performance of a nucleic acid testing(NAT) system for blood screening in the high-altitude Nagqu region of Tibet, in order to assess the capability of NAT in high-altitude areas and further enha...

Therapeutic effect of chemoimmunotherapy on breast cancer sensitized by polymerized human cord hemoglobin in mice: a preliminary study

Objective To investigate the effect of polymerized human cord hemoglobin (PolyCHb) in chemoimmunotherapy for breast cancer in mice. Methods A 4T1 breast cancer in situ tumor model was established, and 15 mice were random...

Recruitment strategies of blood donors during the COVID-19 epidemic

Objective To explore the recruitment strategy of blood donors under the situation of blood supply shortage during the COVID-19 epidemic. Methods The theory of planned behavior and the stage change model of behavior were...

Application of closed-loop blood transfusion information system in the whole process management of blood transfusion

Objective To explore the effect of mobile transfusion closed-loop information system in the whole process management of clinical blood transfusion. Methods The hospital information system (HIS) of Soochow Hospital affili...

Study on the distribution of ABO blood group in patients with pancreatic cancer

Objective To investigate whether there is a correlation between the differences in ABO blood group distribution in patients with pancreatic cancer, and to evaluate the relative risk. Methods Patients with pathological di...

Download PDF file
  • EP ID EP738402
  • DOI 10.13303/j.cjbt.issn.1004-549x.2022.11.007
  • Views 33
  • Downloads 0

How To Cite

Jiabin XU, Yawen LI, Jiali GONG, Erhua LUO, Meng ZHANG (2022). Study on separation and purification process of C1 esterase inhibitor. Chinese Journal of Blood Transfusion, 35(11), -. https://europub.co.uk/articles/-A-738402